Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|September 3, 2010
Optimal use of raltegravir (Isentress(R)) in the treatment of HIV-infected adults - Canadian consensus guidelinesAnita Rachlis, Jonathan B Angel, Marianne Harris, et al.
HIV Clinical Trials|January 10, 2017
Efficacy and safety of "unboosting" atazanavir in a randomized controlled trial among HIV-infected patients receiving tenofovir DFMarianne Harris, Bruce Ganase, Birgit Watson, et al.
The Journal of Infectious Diseases|June 26, 2003
Rates of disease progression among human immunodeficiency virus-infected persons initiating multiple-drug rescue therapyNelson Lee, Robert S Hogg, Benita Yip, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 30, 2020
Impact of Loneliness on Brain Health and Quality of Life Among Adults Living With HIV in CanadaMarianne Harris, Marie-Josée Brouillette, Susan C Scott, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 11, 2019
Relationships between cognition, function, and quality of life among HIV+ Canadian menNancy E Mayo, Marie-Josée Brouillette, Susan C Scott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 27, 2004
Nucleoside-related mitochondrial toxicity among HIV-infected patients receiving antiretroviral therapy: insights from the evaluation of venous lactic acid and peripheral blood mitochondrial DNAJulio S G Montaner, Hélène C F Côté, Marianne Harris, et al.
Therapeutic Drug Monitoring|September 24, 2004
Simplification of therapeutic drug monitoring for twice-daily regimens of lopinavir/ritonavir for HIV infectionChristopher S Alexander, Julio S G Montaner, Jérôme J Asselin, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 30, 2021
A longitudinal view of successful aging with HIV: role of resilience and environmental factorsNancy E Mayo, Marie-Josée Brouillette, Lyne Nadeau, et al.
The Journal of Infectious Diseases|October 20, 2005
Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3Adrienne R Toulson, Richard Harrigan, Katherine Heath, et al.
Current HIV Research|September 7, 2013
Evaluation of treatment tolerability, satisfaction and laboratory parameters in HIV+ patients switching from ritonavir capsule to tablet formulationAndy Mtambo, Marianne Harris, Junine Toy, et al.
Pageof 10